SNAP47 Gene — Synaptosome-Associated Protein 47

SNAP47 Gene — Synaptosome-Associated Protein 47

Overview

SNAP47 (Synaptosome-Associated Protein 47) is a neuronal SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein that plays essential roles in synaptic vesicle trafficking and neurotransmitter release. While SNAP25, SNAP23, and VAMP2 (synaptobrevin-2) have been studied extensively, SNAP47 represents a more recently characterized member of the SNAP family with distinct functional properties. SNAP47 is expressed primarily in neurons and is involved in both constitutive and regulated secretory pathways. Recent research has implicated SNAP47 in the pathogenesis of Alzheimer's disease and other neurodegenerative disorders, making it an important target for mechanistic studies.

SNAP47 Gene — Synaptosome-Associated Protein 47

Overview

SNAP47 (Synaptosome-Associated Protein 47) is a neuronal SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein that plays essential roles in synaptic vesicle trafficking and neurotransmitter release. While SNAP25, SNAP23, and VAMP2 (synaptobrevin-2) have been studied extensively, SNAP47 represents a more recently characterized member of the SNAP family with distinct functional properties. SNAP47 is expressed primarily in neurons and is involved in both constitutive and regulated secretory pathways. Recent research has implicated SNAP47 in the pathogenesis of Alzheimer's disease and other neurodegenerative disorders, making it an important target for mechanistic studies.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SNAP47 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SNAP47</td></tr>
<tr><td><strong>Full Name</strong></td><td>Synaptosome-Associated Protein 47</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>1q41</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[115024](https://www.ncbi.nlm.nih.gov/gene/115024)</td></tr>
<tr><td><strong>OMIM</strong></td><td>608169</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000143740</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BTN2](https://www.uniprot.org/uniprot/Q9BTN2)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>355 amino acids</td></tr>
<tr><td><strong>Protein Class</strong></td><td>SNARE protein (Q-SNARE)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Intellectual Disability](/diseases/intellectual-disability), Epilepsy</td></tr>
</table>
</div>

Discovery and Nomenclature

SNAP47 was discovered in 2006 through a systematic analysis of SNAP family members in the nervous system. The gene encodes a protein with significant homology to other SNAP proteins but with distinct expression patterns and functional properties. The name "SNAP47" reflects its molecular weight and membership in the SNAP protein family.

Initial characterization revealed that SNAP47 is a brain-specific protein, distinguishing it from the more widely expressed SNAP25 and SNAP23. This neuronal specialization suggests specialized functions in synaptic transmission.

Protein Structure

Domain Architecture

SNAP47 possesses the characteristic structure of a Q-SNARE protein:

• Multiple lysine residues for membrane association
• Regulatory domains for protein interactions

• 60-70 amino acid coiled-coil domain
• Contains heptad repeats characteristic of SNARE proteins
• Forms the core of the SNARE complex

• Single transmembrane helix
• Anchors the protein to vesicle or plasma membranes
• Can be modified by palmitoylation

Structural Features

The SNARE motif of SNAP47 contains:

• Zero-layer: Centralionic layer with one arginine (R) residue
• Flanking layers: 8 additional layers contributing to complex stability
• Hydrophobic layers: Form the core of the SNARE bundle

SNARE Complex Formation

The SNARE Machinery

SNARE proteins form ternary complexes that mediate vesicle fusion:

SNARE Complex Composition:
├── Q-SNAREs (target membrane)
│ ├── SNAP47 (Qa-SNARE)
│ ├── SNAP25 (Qb + Qc-SNARE)
│ └── Syntaxin (Qa-SNARE)
└── R-SNARE (vesicle membrane)
└── VAMP2/synaptobrevin-2

SNAP47-Specific Interactions

SNAP47 specifically interacts with:

SNARE Complex Assembly

The assembly of SNAP47-containing SNARE complexes follows a stepwise process:

Expression Pattern

Brain Expression

SNAP47 exhibits neuron-specific expression:

• Highest expression in hippocampus (CA1-CA3 regions)
• Strong expression in cerebral cortex
• Moderate expression in cerebellum
• Lower expression in basal ganglia

• Synaptic vesicles (presynaptic terminals)
• Plasma membrane (presynaptic)
• Some expression in dendrites

• Primarily associated with synaptic vesicles
• Also present at plasma membrane
• Dynamic cycling between compartments

Developmental Expression

SNAP47 expression changes during development:

• Low expression in embryonic brain
• Dramatic increase during first postnatal week
• Adult expression stabilizes at high levels
• Maintained throughout lifespan

Role in Synaptic Transmission

Neurotransmitter Release

SNAP47 is essential for neurotransmitter release through multiple mechanisms:

Synaptic Vesicle Cycle

SNAP47 participates in all stages of the synaptic vesicle cycle:

Synaptic Vesicle Cycle:

Calcium Sensing

While SNAP47 itself does not bind calcium directly:

• Synaptotagmin (calcium sensor) triggers fusion
• SNAP47-containing complexes are calcium-responsive
• The entire SNARE machinery responds to calcium influx

Role in Neurodegenerative Diseases

Alzheimer's Disease

Multiple lines of evidence implicate SNAP47 in AD pathogenesis:

• Reduced expression in early AD
• Correlation with cognitive decline
• Altered synaptic localization

• Impairs SNARE complex formation
• Reduces neurotransmitter release
• Contributes to synaptic failure

• Phosphorylated tau affects SNAP47 trafficking
• Loss of SNAP47 function in tauopathy

• Reduced release probability
• Impaired vesicle replenishment
• Synaptic depression

Epilepsy

SNAP47 is implicated in epileptogenesis:

• Altered expression in epileptic tissue
• Contributes to network hyperexcitability
• Potential therapeutic target

Intellectual Disability

Rare variants in SNAP47 have been associated with:

• Developmental disorders
• Cognitive impairment
• Syndromic intellectual disability

Interaction Partners

Core SNARE Machinery

SNAP47 directly interacts with:

| Partner | Interaction Type | Functional Role |
|---------|-----------------|-----------------|
| VAMP2 | SNARE complex | R-SNARE partner |
| SNAP25 | Alternative Q-SNARE | Can substitute |
| Syntaxin-1 | Q-SNARE partner | Target membrane |
| Munc13-1 | Regulatory | Priming factor |
| Complexin | Modulatory | Release clamp |
| Munc18 | Regulatory | Syntaxin binding |

Accessory Proteins

Additional interactors include:

• Synaptophysin: Vesicle protein
• Synaptotagmin: Calcium sensor
• Rim proteins: Active zone organization
• Piccolo/Ribeye: Active zone scaffold

Regulation of SNAP47 Function

Post-Translational Modifications

Transcriptional Regulation

SNAP47 expression is regulated by:

• Neural activity (activity-dependent)
• Transcription factors (CREB, Npas4)
• Epigenetic mechanisms

Pathological Dysregulation

Disease states alter SNAP47:

• Proteolytic cleavage in neurodegeneration
• Mislocalization in disease
• Aggregation in stress conditions

Therapeutic Implications

Drug Target Potential

SNAP47 represents a potential therapeutic target:

• Small molecules enhancing SNARE function
• Peptide mimetics stabilizing complexes
• Gene therapy approaches

• Alzheimer's disease (enhance synaptic function)
• Epilepsy (modulate network excitability)
• Stroke (protect against excitotoxicity)

Biomarker Potential

SNAP47 as a biomarker:

• CSF levels reflect synaptic health
• Peripheral detection possible
• Correlation with disease stage

Animal Models

Knockout Studies

SNAP47 knockout mice exhibit:

• Viable and fertile (partial redundancy)
• Impaired neurotransmitter release
• Learning and memory deficits
• Age-dependent neurodegeneration

Transgenic Models

Transgenic overexpression studies show:

• Enhanced release probability
• Altered short-term plasticity
• Modified seizure susceptibility

Comparison with Other SNAP Proteins

| Feature | SNAP25 | SNAP23 | SNAP47 |
|---------|--------|--------|--------|
| Tissue Expression | Neuronal | Ubiquitous | Neuronal |
| Isoforms | SNAP25A/B | SNAP23 | Single |
| Chain Length | 2 (SNAP25) | 2 | 1 |
| Disease Links | Botulism, AD | Inflammation | AD, Epilepsy |
| Essentiality | Essential | Essential | Redundant |

Future Directions

Unanswered Questions

Research Priorities

See Also

• [SNAP25 Gene](/genes/snap25)
• [VAMP2 Gene](/genes/vamp2)
• [Synaptic Vesicle Cycle](/cell-types/synaptic-vesicle-cycle)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Synaptic Vesicle Trafficking](/mechanisms/synaptic-vesicle-trafficking)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Neurotransmitter Release](/mechanisms/neurotransmitter-release)
• [SNARE Complex](/mechanisms/snare-complex-assembly)

External Links

• [NCBI Gene: SNAP47](https://www.ncbi.nlm.nih.gov/gene/115024)
• [UniProt: Q9BTN2](https://www.uniprot.org/uniprot/Q9BTN2)
• [Ensembl: ENSG00000143740](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143740)
• [PubMed: SNAP47](https://pubmed.ncbi.nlm.nih.gov/?term=SNAP47+synapse)

References